A team of international researchers led by Karolinska Institutet has revealed in unprecedented detail how tetracycline antibiotics impair T cell function by binding mitochondrial ribosomes and ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for serious and life-threatening bacterial ...
A new open-access review proposes attacking both the upstream enzymes of the bacterial shikimate pathway and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results